Interleukin-5 Antagonists [MoA] - N0000191871

Pharmacologic Class Information

Pharmacologic Code N0000191871
Pharmacologic Name Interleukin-5 Antagonists
Pharmacologic Uses
  • interleukin-5 antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Interleukin-5 Antagonists

The following table contains 4 products whose active ingredient are classified under the same pharmacologic class Interleukin-5 Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0173-0881Nucala Non-Proprietary Name: MepolizumabInjection, Powder, For SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0892Nucala Non-Proprietary Name: MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0904Nucala Non-Proprietary Name: MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
59310-610Cinqair Non-Proprietary Name: ReslizumabInjection, Solution, ConcentrateIntravenousTeva Respiratory, LlcACTIVE